Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities (original ) (raw )Treatment of Recurrent Sarcoma of the Extremities by Isolated Limb Perfusion Using Tumor Necrosis Factor Alpha and Melphalan
Renato Manzi
Tumori Journal, 1996
View PDFchevron_right
Long-Term Results of Tumor Necrosis Factor - and Melphalan-Based Isolated Limb Perfusion in Locally Advanced Extremity Soft Tissue Sarcomas
J. de Wilt
Journal of Clinical Oncology, 2011
View PDFchevron_right
Advanced Extremity Soft Tissue Sarcoma: Prognostic Effect of Isolated Limb Perfusion in a Series of 88 Patients Treated at a Single Institution
Mario Santinami
Annals of Surgical Oncology, 2007
View PDFchevron_right
Isolated Limb Perfusion with Tumor Necrosis Factor and Melphalan for Limb Salvage in 186 Patients with Locally Advanced Soft Tissue Extremity Sarcomas
Alexander Eggermont
Annals of Surgery, 1996
View PDFchevron_right
Hyperthermic isolated limb perfusion in locally advanced limb soft tissue sarcoma: A 24-year single-centre experience
Luca Giovanni Campana
International Journal of Hyperthermia, 2015
View PDFchevron_right
Hyperthermic Isolated Limb Perfusion in Locally Advanced Soft Tissue Sarcoma and Progressive Desmoid-Type Fibromatosis with TNF 1 mg and Melphalan (T1-M HILP) Is Safe and Efficient
Sylvie Bonvalot , Françoise Rimareix
Annals of Surgical Oncology, 2009
View PDFchevron_right
Isolated limb perfusion with tumor necrosis factor-? and melphalan for patients with unresectable soft tissue sarcoma of the extremities
Frits van Coevorden
Cancer, 2003
View PDFchevron_right
Limb salvage by neoadjuvant isolated perfusion with TNFα and melphalan for non-resectable soft tissue sarcoma of the extremities
François Mosimann
European Journal of Surgical Oncology, 2000
View PDFchevron_right
Isolated limb perfusion with melphalan and TNF-alpha in the treatment of extremity sarcoma
Alexander Eggermont
2007
View PDFchevron_right
Isolated limb perfusion with tumor necrosis factor and melphalan for non‐resectable soft tissue sarcomas: Long‐term results on efficacy and limb salvage in a selected …
Robert van Ginkel
Journal of surgical …, 2008
View PDFchevron_right
TNF dose reduction and shortening of duration of isolated limb perfusion for locally advanced soft tissue sarcoma of the extremities is safe and effective in terms of long-term patient outcome
Robert van Ginkel
Journal of Surgical Oncology, 2011
View PDFchevron_right
Isolated Limb Perfusions With Tumor Necrosis Factor and Melphalan for Locally Recurrent Soft Tissue Sarcoma in Previously Irradiated Limbs
J. de Wilt
Annals of Surgical Oncology, 2005
View PDFchevron_right
Efficacy of high vs low dose TNF-isolated limb perfusion for locally advanced soft tissue sarcoma
Mordechai Gutman
European Journal of Surgical Oncology (EJSO), 2009
View PDFchevron_right
Angiographic response of locally advanced soft-tissue sarcoma following hyperthermic isolated limb perfusion with tumor necrosis factor
Ineke Molenaar
Annals of Surgical Oncology, 1997
View PDFchevron_right
Isolated limb perfusion for the management limb threatening soft tissue sarcomas: The role of histological type on clinical outcomes
Giovanni Scarzello
European Journal of Surgical Oncology (EJSO), 2017
View PDFchevron_right
Long Term Outcome of Preoperative Isolated Limb Infusion and External Irradiation in Management of Locally Advanced Extremity Soft Tissue Sarcoma
sherif kotb
The Open Surgical Oncology Journal, 2011
View PDFchevron_right
Other primary neoplasms in patients with soft tissue sarcomas of the extremities treated with isolated limb perfusion
Robert van Ginkel
View PDFchevron_right
Isolated Limb Infusion for Advanced Soft Tissue Sarcoma of the Extremity
Hidde Kroon
Annals of Surgical Oncology, 2008
View PDFchevron_right
Fifty Tumor Necrosis Factor?Based Isolated Limb Perfusions for Limb Salvage in Patients Older Than 75 Years With Limb-Threatening Soft Tissue Sarcomas and Other Extremity Tumors
Alexander Eggermont
Annals of Surgical Oncology, 2003
View PDFchevron_right
The role of hyperthermic perfusion as a first step in the treatment of soft tissue sarcoma of the extremities
Renato Cavaliere
World Journal of Surgery, 1988
View PDFchevron_right
The oncological outcomes of isolated limb perfusion and neo-adjuvant radiotherapy in soft tissue sarcoma patients - A nationwide multicenter study
Veroniek van Praag
European Journal of Surgical Oncology
View PDFchevron_right
Soft Tissue Cancer Management: Isolated Limb Infusion for Sarcoma
Pille Pata
Visceral medicine, 2019
View PDFchevron_right
Hyperthermic isolated limb perfusion for recurrent melanomas and soft tissue sarcomas: Feasibility and reproducibility in a multi-institutional Hellenic collaborative study
Christos V Ioannou
Oncology Reports, 2010
View PDFchevron_right
Isolated limb perfusion with tumour necrosis factor-α and melphalan for unresectable bone sarcomas of the lower extremity
Eric Manusama
Ejso, 1999
View PDFchevron_right
Long-term Results of Hyperthermic, Isolated Limb Perfusion for Melanoma
Peter Kam
Annals of Surgery, 2007
View PDFchevron_right
Isolated limb perfusion for unresectable extremity sarcoma
Curtis Wray
Cancer, 2011
View PDFchevron_right
Isolated Limb Perfusion in the Treatment of Advanced Soft-tissue Sarcomas
Martin Malawer
Musculoskeletal Cancer Surgery, 2004
View PDFchevron_right